BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16604308)

  • 1. Screening for cognitive impairment in Parkinson's disease--which marker relates to disease severity?
    Riepe MW; Kassubek J; Tracik F; Ebersbach G
    J Neural Transm (Vienna); 2006 Oct; 113(10):1463-8. PubMed ID: 16604308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment is associated with Hoehn and Yahr stages in early, de novo Parkinson disease patients.
    Siciliano M; De Micco R; Trojano L; De Stefano M; Baiano C; Passaniti C; De Mase A; Russo A; Tedeschi G; Tessitore A
    Parkinsonism Relat Disord; 2017 Aug; 41():86-91. PubMed ID: 28576605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive function assessment in idiopathic Parkinson's disease.
    Piovezan MR; Teive HA; Piovesan EJ; Mader MJ; Werneck LC
    Arq Neuropsiquiatr; 2007 Dec; 65(4A):942-6. PubMed ID: 18094850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interlocking finger test in patients with Parkinson's disease and healthy subjects.
    Souza CP; Oliveira GN; Foss MP; Tumas V
    J Clin Neurosci; 2016 Jul; 29():145-8. PubMed ID: 26960261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olfactory deficits and cognitive dysfunction in Parkinson's disease.
    Parrao T; Chana P; Venegas P; Behrens MI; Aylwin ML
    Neurodegener Dis; 2012; 10(1-4):179-82. PubMed ID: 22343138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postural/Gait and cognitive function as predictors of driving performance in Parkinson's disease.
    Crizzle AM; Classen S; Lanford DN; Malaty IA; Okun MS; Wang Y; Wagle Shukla A; Rodriguez RL; McFarland NR
    J Parkinsons Dis; 2013; 3(2):153-60. PubMed ID: 23938345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CERAD test performance and cognitive impairment in Parkinson's disease.
    Karrasch M; Laatu S; Martikainen K; Marttila R
    Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postural instability and cognitive dysfunction in early Parkinson's disease.
    Lee JM; Koh SB; Chae SW; Seo WK; Kwon DY; Kim JH; Oh K; Baik JS; Park KW
    Can J Neurol Sci; 2012 Jul; 39(4):473-82. PubMed ID: 22728854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild cognitive impairment in Parkinson's disease: the Parkinson's disease cognitive study (PACOS).
    Monastero R; Cicero CE; Baschi R; Davì M; Luca A; Restivo V; Zangara C; Fierro B; Zappia M; Nicoletti A
    J Neurol; 2018 May; 265(5):1050-1058. PubMed ID: 29478221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Instrumental activities of daily living in Parkinson's disease dementia as compared with Alzheimer's disease: relationship to motor disability and cognitive deficits: a pilot study.
    Rasovska H; Rektorova I
    J Neurol Sci; 2011 Nov; 310(1-2):279-82. PubMed ID: 21851954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health comorbidities and cognition in 1948 patients with idiopathic Parkinson's disease.
    Jones JD; Malaty I; Price CC; Okun MS; Bowers D
    Parkinsonism Relat Disord; 2012 Dec; 18(10):1073-8. PubMed ID: 22776043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of parkinsonian syndromes according to differences in executive functions.
    Lange KW; Tucha O; Alders GL; Preier M; Csoti I; Merz B; Mark G; Herting B; Fornadi F; Reichmann H; Vieregge P; Reiners K; Becker G; Naumann M
    J Neural Transm (Vienna); 2003 Sep; 110(9):983-95. PubMed ID: 12938023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition.
    Phannarus H; Muangpaisan W; Siritipakorn P; Chotinaiwattarakul W
    Psychogeriatrics; 2020 Jan; 20(1):20-27. PubMed ID: 30912230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease.
    Bohnen NI; Kotagal V; Müller ML; Koeppe RA; Scott PJ; Albin RL; Frey KA; Petrou M
    Parkinsonism Relat Disord; 2014 Dec; 20(12):1394-8. PubMed ID: 25454317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological impairment in Parkinson's disease with and without depression.
    Tröster AI; Stalp LD; Paolo AM; Fields JA; Koller WC
    Arch Neurol; 1995 Dec; 52(12):1164-9. PubMed ID: 7492290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between motor symptom lateralization and cognitive performance in newly diagnosed drug-naïve patients with Parkinson's disease.
    Poletti M; Frosini D; Pagni C; Baldacci F; Giuntini M; Mazzucchi S; Tognoni G; Lucetti C; Del Dotto P; Ceravolo R; Bonuccelli U
    J Clin Exp Neuropsychol; 2013; 35(2):124-31. PubMed ID: 23216295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The cognitive dysfunction in Parkinson's disease].
    Kanazawa A
    Nihon Rinsho; 2004 Sep; 62(9):1679-84. PubMed ID: 15462384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment in Parkinson's disease without dementia.
    Rodríguez-Ferreiro J; Cuetos F; Herrera E; Menéndez M; Ribacoba R
    Mov Disord; 2010 Oct; 25(13):2136-41. PubMed ID: 20725913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.